The effect of dimethylarsenics on the pulmonary tumorigenesis initiated by 4-nitroquinoline 1-oxide (4NQO) in mice was examined. The exposure of mice to dimethylarsinic acid (DMAA), a major metabolite of inorganic arsenics in mammals, resulted in not only promotion but also progression of the tumorigenic process in the lungs of mice administered 4NQO. Furthermore, dimethylarsenics influenced the differentiation process in lung tumorigenesis by 4NQO-These results may pave the way for the elucidation of lung carcinogenesis caused by arsenics.
Introduction
Although epidemiological investigations have shown that inorganic arsenics are carcinogenic in human subjects, particularly in the skin and lungs, experimental studies on the carcinogenicity of inorganic arsenics have not yet yielded positive results (1,2). To solve this discrepancy, we have focused on the action of metabolites of inorganic arsenics, since they are known to be readily metabolized to methylated arsenics (3) (4) (5) (6) (7) . We found that an oral administration of dimethylarsinic acid (DMAA*), a main metabolite of inorganic arsenics, induced lung-specific genetic damage in mice in vivo, i.e. DNA single-strand breaks (8, 9) and an increase in heterochromatin content (10). The DNA damage was analyzed more in detail by using human pulmonary cultured cells in vitro; DMAA exposure caused, besides DNA single-strand breaks (11), DNA-protein crosslinks (12), formation of apurinic/apyrimidinic sites in the DNA (13) and nucleic base damage (11,13). These kinds of damage by dimethylarsenics are assumed to be due to the dimethylarsenic peroxyl radical [(CH 3 ) 2 As0O] produced in the further metabolic processing of DMAA (14) .
As regards the participation of free radicals in skin and lung carcinogenesis, some studies have indicated that free radical-producing agents such as 12-0-tetradecanoylphorbol-13-acetate (TPA) (15) , butylated hydroxytoluene (BHT) (16) and glycerol (17) act as tumor promotors. Among these agents, glycerol is known to have potent promoting activity in lung tumorigenesis initiated by administration of 4-nitroquinoline 1-oxide (4NQO) in ddY mice (18) .
•Abbreviations: DMAA, dimethylarsinic acid; TPA, 12-0-tetradecanoyIphorbol-13-acetate; BHT, butylated hydroxytoluene; 4NQO, 4-nitroquinoline 1-oxide; SOD, superoxide dismutase.
The present paper describes the effect of dimethylarsenics on lung tumorigenesis in mice initiated by 4NQO. We found that the oral administration of DMAA showed not only promotion activity but also progression activity in mouse-lung tumorigenesis induced by 4NQO and, further, influenced the differentiation process in the lung tumorigenesis.
Materials and methods

Animals
Six-week-old maJe ddY mice were obtained from Japan SLC (Hamamatsu, Japan). Three to five mice were housed for 25 weeks in a cage under conventional clean conditions at 23°C and 55% humidity and a 12 h light/ dark-cycle, and were given free access to food and drinking water.
Chemicals
DMAA and glycerol were purchased from Nakarai Tesque (Kyoto, Japan) and Wako Pure Chemical Industries Ltd (Osaka, Japan) respectively. 4NQO was from Iwai Kagaku Yakuhin Co. Ltd (Tokyo, Japan). Olive orl and cholesterol were obtained from Wako.
Mouse pulmonary carcinogenesis assay
Pulmonary carcinogenesis assay using ddY mice was based on the short-term promotion assay described by Inayama (18) . Mice were divided into four groups. The groups of 9-13 mice were given tap water, 5% glycerol solution, or 200 or 400 p.p.m. DMAA solution as drinking water ad libitum for 25 weeks after injection of 4NQO (10 mg/kg, s.c.) suspended in the mixture of olive oil and cholesterol (20:1). Under anesthesia with sodium pentobarbital, the lung, liver, kidney, spleen, stomach, bladder, etc., were excised rapidly, and were then fixed in 10% buffered formalin. Tumors on the lung surface were scored under a dissecting microscope, followed by histopathological survey to confirm their neoplastic nature, as well as that of other pulmonary tumorigenesis, by light microscopic examination.
Results and discussion
The concentration (200 or 400 p.p.m.) of DMAA used here was decided based on a preliminary experiment indicating that these doses were neither lethal nor apparently toxic; the rates of body weight gain calculated from the weight on the first and the last experimental days were 1.62 ± 0.06 in group 1, 1.53 ± 0.06 in group 2, 1.43 ± 0.06 in group 3, and 1.58 ± 0.04 in group 4. No significant difference was seen among them. The average DMAA intake in groups 3 and 4 was 784 ± 19 and 1339 ± 27 mg/mouse/day respectively, based on measurements taken every week.
Male ddY mice pretreated with 4NQO, which is known as an initiator of lung tumors, were given DMAA, a main metabolite of inorganic arsenics, and the number of nodules formed in the peripheral lungs was counted as an indicator of carcinogenesis (Table I ). The percentage of mice bearing tumor nodules was increased more by administration of both 4NQO and DMAA than by 4NQO alone, or by both 4NQO and glycerol, and furthermore, the average number of tumor nodules per mouse was significantly higher in those administered DMAA than those given glycerol. This result suggests that dimethylarsenics have a stronger promoting activity than glycerol, which is known to have a potent promotion activity for lung tumors induced by 4NQO (18) . On the other hand, the tumor was not observed in any other tissues throughout The mice were given tap water (group 1), glycerol solution (group 2) or DMAA solution (groups 3 and 4) ad libitum for 25 weeks after s.c. injection of 4NQO (10 mg/kg).
•Significant difference from group 2 (P < 0.05, Cochran-Cox r-test). the experiment shown in Table I . Furthermore, no tumor was observed in not only lung but also any other tissues by DMAA administration alone without 4NQO treatment (data not shown).
Next, we conducted a histopathological study on lung tumors promoted by dimethylarsenics. It is known that the s.c. injection of 4NQO in mice induces tumors originating in Clara cells and alveolar type n cells (19) . As a result of the histopathological examination of all the lungs, we observed that the majority (~90 %) of peripheral lung tumors induced by 4NQO and glycerol proliferated as tubular and papillary-type growths with rather benign cells (Figure la) , whereas all the tumors induced by 4NQO and DMAA showed more atypism, such as nuclear hyperchromasia, larger nucleocytoplasmic ratio, irregular cell arrangement and more solid growth, either throughout or in part of the tumors, and proceeded apparently to adenocarcinomas (Figure lb) . Some of the tumors contained periodic acid-Schiff-positive material in their lumens (Figure   768 lc). These results suggest that the tumors may be promoted to adenocarcinomas and that dimethylarsenics have not only tumor-promoting activity but also progression activity in 4NQO-initiated lung tumorigenesis.
In the groups administered both 4NQO and 200 p.p.m. DMAA, multiple formation of peripheral adenosquamous carcinomas in lung was demonstrated by alcian blue staining, by which regions of acidic myxiosis were observed in the squamous cell carcinomas ( Figure 2 ). As regards this formation, two possibilities may be considered: metaplastic formation of squamous carcinoma from adenocarcinoma; and metastasis from squamous carcinoma in other tissues. As no squamous cell carcinomas were observed in other tissues and organs at all, the latter possibility can be rejected. These results suggest that the carcinomas may be adenosquamous carcinomas produced by metaplasia.
Inorganic arsenics, e.g. arsenite and arsenate, are epidemiologically known to be carcinogenic for lung and skin; nevertheless, the evidence of their carcinogenicity in experimental animals has not yet been given (1,2). A recent report indicated that DMAA acts as tumor promoter of urinary, bladder, kidney, liver and thyroid gland carcinogenesis in F344 rats, and further that this action may be related to arsenic carcinogenesis in humans (20) . However, the data obtained from rats may have a problem because the metabolism of arsenics in rats is unique and quite different from that in human subjects or other animals (21) .
Earlier we investigated the participation of the metabolic methylation pathway of inorganic arsenics in pulmonary genetic damage. As results, we found that some free radical species, particularly dimethylarsenic peroxyl radicals produced in the metabolic processing of inorganic arsenics, were responsible for DNA damage such as DNA single-strand breaks (8, 9) and DNA-protein crosslinks (10) caused by the formation of apurinic/apyrimidinic sites in the DNA, and further suggested that these types of damage might occur via the formation of DNA adducts (12). As regards the participation of free radical species in the toxicity of inorganic arsenics, a recent report also indicated that superoxide dismutase (SOD) and catalase protected against arsenic toxicity and reduced chromosomal aberration in cultured cells (22) . In a system using hamster embryonic cells, the promotion activity of TPA is known to be suppressed by SOD (15) . Furthermore, in mouse skin tumorigenesis initiated by 7, 12-dimethylbenzanthracene, the promoting activity of TPA is suppressed by SOD-like substances (23) . These findings suggest that the production of active oxygen species is closely related to the tumor promotion process. Therefore, we assume that the promotion activity of dimethylarsenics may be also due to the action of active oxygen species or related radicals such as dimethylarsenic peroxyl radicals.
In the present study, we document the possibility of induction of lung cancer by dimethylarsenics. In particular, it seems reasonable to emphasize that dimethylarsenics possess not only promoting activity but also progression activity for lung cancer induction. Among a number of tumor promoters, there are only a few recognized promoters for lung carcinogenesis, e.g. glycerol for 4NQO-initiated, and BHT for urethane-initiated carcinogenesis. Dimethylarsenics, however, may have a more potent promoting activity than these promoters.
